Imaging & Radiology

Clinical-stage developer of Eye90 microspheres, an yttrium-90 radioembolization device made from a glass composition that stays visible during the procedure. Indicated work targets benign and malignant hypervascular tumors, including liver cancer.

Redesigned MRI hardware for mobile cancer screening and runs the scanners itself as trailer-based imaging clinics billed per scan, starting with prostate imaging before biopsy.

Sells FDA-cleared AI triage and quantification software for CT and X-ray through its aiOS platform, now built on the CARE foundation model. More than 30 510(k) clearances since 2018.

Sells SwiftMR, software that shortens MRI scan times and improves image quality on existing scanners, plus SwiftSight quantitative imaging. Works with Siemens, GE, Philips and Canon systems without hardware changes.

Quantitative MRI software that measures fat and muscle composition from a whole-body scan and returns body composition biomarkers for metabolic and musculoskeletal assessment.

Builds xvision, an augmented reality navigation system for spine surgery that projects CT anatomy onto a headset the surgeon wears. Its second generation X2 headset was cleared in 2025.

Develops ophthalmic imaging hardware and AI diagnostic software, including the MIAS-3000 OCT analysis system cleared as a Class III device in China.

Bunkerhill Health develops FDA-cleared AI algorithms that find cardiovascular and bone disease on imaging and ECGs ordered for other reasons. Hospitals run them through its Carebricks platform.

Develops AI software that quantifies coronary inflammation and plaque from coronary CT angiography to predict cardiac risk. University of Oxford spinout with a U.S. office in Stamford, Connecticut.

Sells Clairity Breast, FDA-authorized software that estimates a woman's five-year breast cancer risk from an existing screening mammogram. Now also offered directly to patients through Everlywell.

Builds vision language models that read imaging studies and draft radiology reports. Acquired by Radiology Partners' Mosaic Clinical Technologies in November 2025.

The Novasight Hybrid system images coronary arteries with intravascular ultrasound and optical coherence tomography at the same time, co-registered in one pullback.

Curadel Surgical Innovations develops near-infrared fluorescent contrast agents for image-guided surgery, led by ZW800-1 for visualizing the ureters during abdominal and pelvic procedures.

Remote robotic ultrasound platform that lets a sonographer run a diagnostic imaging exam on a patient in another location.

Builds the Op.n surgical platform, which combines 2D and 3D imaging, navigation and robotic guidance for spine and orthopedic procedures, and is open to third party implants and applications. Enovis agreed to acquire the company in September 2026.

Builds PlaqueIQ, FDA-cleared software that quantifies plaque composition from coronary CT angiography, and a BioIntegrated FFR-CT product under FDA review.

Works on ultrasound based brain computer interfaces, neuromodulation and functional ultrasound imaging, all without an implant. Registered in September 2025 and announced its launch in January 2026.

Australian medical AI company behind the Annalise radiology decision-support tools for chest X-ray, CT brain and CT chest, and the Franklin.ai pathology platform.

HistoSonics makes the Edison histotripsy system, which uses focused ultrasound to destroy liver tumors without incisions, heat or radiation.

King's College London spinout selling HyperSnap, a hyperspectral imaging system that shows tissue oxygenation and composition during surgery. Cleared under K250268 in June 2025 with product code SFE.

Makes Skylight, a system that projects medical images onto the patient during procedures so surgeons do not use a headset or look away at a monitor. Aimed at spine surgery, pain management and interventional radiology.

Makes a compact automated scanner that captures a 3D ultrasound volume of the breast in about a minute, with machine learning applied to flag abnormal masses.

Krinwave builds the kOS ultrasound imaging platform for deep tissue imaging in neurology, abdominal and cardiovascular exams.

Builds VERAFEYE, a catheter-based cardiac imaging and navigation platform that produces 2D, 3D and 4D views of the heart and tracks imaging and ablation catheters during electrophysiology procedures.

Building real time 3D ultrasound systems meant to replace 2D imaging for procedures such as vascular access and central line placement.

Builds Focalist, a handheld robotic system that guides needle placement using real-time ultrasound. Used for vascular access, regional nerve blocks and organ access.

Software that denoises and sharpens MRI and PET images using random matrix theory and MR-guided reconstruction. A spinout of NYU Langone Health.

Builds robotic microscopes and vision guided scanning systems for cancer diagnostics and digital pathology.

Makes NextMR, software that generates 3D bone visualization of the lumbar spine and sacrum from a standard diagnostic MRI, removing the need for a separate CT scan.

BoneMRI software builds a CT-like 3D view of bone from an MRI scan, so bone structures can be read and surgical plans made without the radiation dose. A University of Utrecht spin-off.

Handheld imaging device using frequency domain near infrared spectroscopy to indicate within a week of starting treatment whether a breast cancer therapy is working.

Builds the nView s1, a low-dose 3D imaging and surgical guidance system that uses the patient's own anatomy as the navigation map, with pediatric surgery as its focus.

Builds Quicktome, software that turns MRI and resting state functional MRI into patient specific maps of brain networks for surgical planning and deep brain stimulation.

Makes the Inova 1 towerless hybrid endoscope system, which puts the camera, light source and display in the scope instead of a cart.

Builds optical coherence tomography systems with AI detection for assessing surgical margins during cancer surgery. Listed on the TSX Venture Exchange as PINK.

Makes a single-sided point-of-care MRI system for prostate procedures, cleared for MRI-guided prostate biopsy, with AI planning and robotic needle guidance still in development.

Pulsenmore makes a smartphone cradle that lets pregnant women perform ultrasound scans at home for remote reading by clinicians. It is listed on the Tel Aviv Stock Exchange.

Makes the Accuro handheld ultrasound system for spinal anesthesia guidance and SpineNav-AI, machine learning software that identifies lumbar spine structures and the spine midline in ultrasound images.

Sells Arthur, a robot that captures standardized ultrasound images of hand and wrist joints, and Diana, the software that analyzes them for rheumatology.

Builds handheld optical coherence tomography systems on a photonic chip, for retinal disease monitoring in clinics and at home.

Software-only cancer imaging company that combines biophysical modeling and machine learning. Its products are TumorSight Viz, TumorSight RISK and the research tool PhenoScope.

Cloud-native radiology platform that combines PACS, diagnostic viewing, reporting and worklist in a single system. Also sells Sirona Cortex, an agentic AI layer for radiology workflow.

Builds DERM, an AI tool that triages suspected skin cancer referrals from lesion images. It is used across NHS dermatology pathways in the UK.

Develops a high intensity focused ultrasound system for non invasive treatment of pancreatic cancer, with real time guidance, cavitation bubble visualization and robot assisted positioning.

Robotic platform called Swan that captures standardized full-body dermoscopic skin images and tracks changes over time with AI.

AI guidance software that walks a clinician without sonography training through a cardiac ultrasound exam. Sold as the EchoSystem platform.

Berlin AI company whose software reads screening mammograms inside Germany's national breast cancer screening program. In September 2026 it received CE certification for a Class IIb autonomous triage function that reports clearly normal exams without a radiologist.

Builds VxWave, a semi-autonomous robot that acquires 3D vascular ultrasound without a sonographer. First use is mapping and monitoring arteriovenous fistulas in dialysis clinics.

Builds AI software that detects suspected disease on medical images and physiological data and routes the case to a specialist. Its Viz HCM device led FDA to create a new Class II regulation for cardiovascular machine learning notification software.